Actively Recruiting
A Phase Ia Clinical Trial of HW241045
Led by Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. · Updated on 2026-03-04
56
Participants Needed
1
Research Sites
27 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a Phase Ia, randomized, double-blind, placebo-controlled study to assess the safety, tolerability and pharmacokinetic (PK) of HW241045 in healthy subjects following a single ascending dose.
CONDITIONS
Official Title
A Phase Ia Clinical Trial of HW241045
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants must be healthy males or females aged 18 to 55 years
- Participants must voluntarily agree to participate and sign informed consent after being fully informed about the trial
- Female participants must weigh at least 45 kg, and male participants must weigh at least 50 kg
- Body mass index (BMI) must be between 19 and 26 kg/m²
You will not qualify if you...
- History of or current severe clinical diseases involving circulatory, endocrine, nervous, digestive, respiratory, hematological, immune, mental, or metabolic systems
- History of severe trauma or major surgery within 3 months prior to screening, or planned surgery during the trial or within two weeks after study completion
- History of gastrointestinal, liver, or kidney diseases affecting drug absorption or metabolism
- Clinically significant abnormalities in screening test results as judged by the investigator
- History of drug or food allergies, allergic disorders, or confirmed hypersensitivity to components of the study drug
- Difficulty with venous blood collection or inability to tolerate intensive blood sampling
- Any other condition that the investigator judges makes the participant unsuitable for the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking Union Medical College Hospital
Beijing, China, 100730
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here